Combining eyelid pressure patching with AMT effectively heals persistent corneal epithelial defects, offering rapid ...

The state-of-the-art facility more than doubles the institute’s footprint, enhancing patient care, research, and education.

A PDUFA date has been set for October 20, 2025. If approved, Epoxia will be the first epi-on corneal crosslinking on the market.

Luxa Biotechnology LLC announced that the US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced ...

At the Envision Summit 2025 in San Juan, Puerto Rico, retina program chairs Geeta Lalwani, MD, and Majda Hadziahmetovic, MD, ...